Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy
The amyloid cascade hypothesis posits that amyloid-β oligomers (AβOs) are the most neurotoxic species in Alzheimer’s disease (AD). These oligomers, characterized by their high β-sheet content, have been shown to significantly disrupt cell membranes, induce local inflammation, and impair autophagy pr...
Saved in:
| Main Authors: | Shiwani Randhawa, Trilok Chand Saini, Manik Bathla, Rahul Bhardwaj, Rubina Dhiman, Amitabha Acharya |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Beilstein-Institut
2025-04-01
|
| Series: | Beilstein Journal of Nanotechnology |
| Subjects: | |
| Online Access: | https://doi.org/10.3762/bjnano.16.44 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The relationship between postoperative delirium and plasma amyloid beta oligomer
by: YoungSoon Yang, et al.
Published: (2025-04-01) -
Recent advances in immunotherapy targeting amyloid-beta and tauopathies in Alzheimer’s disease
by: Sha Sha, et al.
Published: (2026-02-01) -
Amyloid‐β oligomers suppress subunit‐specific glutamate receptor increase during LTP
by: Hiromitsu Tanaka, et al.
Published: (2019-01-01) -
Soluble β-Amyloid Oligomers Selectively Upregulate TRPC3 in Excitatory Neurons via Calcineurin-Coupled NFAT
by: Zhengjun Wang, et al.
Published: (2025-06-01) -
Nitroxyl Hybrids with Curcumin and Stilbene Scaffolds Display Potent Antioxidant Activity, Remodel the Amyloid Beta Oligomer, and Reverse Amyloid Beta-Induced Cytotoxicity
by: Madhu S. Budamagunta, et al.
Published: (2024-11-01)